Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines Journal Article

  


Authors: Zelenetz, A. D.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Bellam, N.; Byrd, J. C.; Czuczman, M. S.; Fayad, L.; Glenn, M. J.; Gockerman, J. P.; Gordon, L. I.; Harris, N. L.; Hoppe, R. T.; Horwitz, S. M.; Kelsey, C. R.; Kim, Y. H.; Krivacic, S.; LaCasce, A. S.; Nademanee, A.; Porcu, P.; Press, O.; Pro, B.; Reddy, N.; Sokol, L.; Swinnen, L.; Tsien, C.; Vose, J. M.; Yahalom, J.; Zafar, N.; Naganuma, M.; Dwyer, M. A.
Article Title: Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines
Abstract: These NCCN Guidelines Insights summarize several key updates to the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Hodgkin's Lymphomas (NHL) and describe the clinical evidence supporting the updates. The featured updates include changes to the recommendations for treatment options in patients with chronic lymphocytic leukemia (including in elderly or frail patients and patients with poor-risk cytogenetics), guidance surrounding surveillance imaging for follow-up of patients with NHL, and the addition of first-line consolidation options for patients with mantle cell lymphoma. © JNCCN - Journal of the National Comprehensive Cancer Network.
Keywords: cancer survival; treatment response; overall survival; fludarabine; prednisone; allogeneic stem cell transplantation; review; doxorubicin; recommended drug dose; unspecified side effect; clinical trials as topic; alpha interferon; cytarabine; methotrexate; rituximab; cancer staging; drug megadose; follow up; carboplatin; progression free survival; computer assisted tomography; mantle cell lymphoma; multiple cycle treatment; etoposide; blood toxicity; evidence based practice; cytogenetics; bendamustine; cyclophosphamide; dexamethasone; vincristine; autologous stem cell transplantation; practice guideline; ifosfamide; procarbazine; high risk patient; nonhodgkin lymphoma; lymphoma, non-hodgkin; mitoxantrone; computer assisted emission tomography; methylprednisolone; large cell lymphoma; corticosteroid; oxaliplatin; chromosome deletion; drug treatment failure; chronic lymphatic leukemia; frail elderly; geriatric patient; follicular lymphoma; alemtuzumab; chlorambucil; pentostatin; induction chemotherapy; cladribine; guidelines as topic; leukemia remission; randomized controlled trial (topic); nonmyeloablative stem cell transplantation; phase 2 clinical trial (topic); phase 3 clinical trial (topic); multicenter study (topic); ofatumumab; consolidation chemotherapy
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 10
Issue: 12
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2012-12-01
Start Page: 1487
End Page: 1498
Language: English
PROVIDER: scopus
PUBMED: 23221787
DOI: 10.6004/jnccn.2012.0155
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84871444162&partnerID=40&md5=1e31c99e1473136d04d1efe3ea294efc
Notes: --- - "Export Date: 2 January 2013" - "Source: Scopus"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Joachim Yahalom
    625 Yahalom
  2. Steven M Horwitz
    645 Horwitz
  3. Andrew D Zelenetz
    767 Zelenetz
Related MSK Work